Alkermes (ALKS) Work In Process (2011 - 2026)
Alkermes (ALKS) posted quarterly Work In Process of $109.2 million for Q2 2026, up 34.17% year-over-year from $81.4 million in Q2 2025, and down 9.64% quarter-over-quarter from $120.8 million in Q1 2026.
Alkermes (ALKS) Work In Process (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Work In Process for 16 consecutive years, with $109.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Work In Process rose 34.17% year-over-year to $109.2 million; the TTM figure through Jun 2026 stood at $109.2 million (up 34.17% YoY), while the FY2025 annual figure was $90.5 million, up 13.31% from the prior year.
- Work In Process eased to $109.2 million in Q2 2026 per ALKS's latest filing, from $120.8 million in the prior quarter.
- Across five years, Work In Process topped out at $120.8 million in Q1 2026 and bottomed at $64.4 million in Q1 2022.
- Historically, Work In Process has averaged $80.6 million across 5 years, with a median of $76.6 million in 2022.
- Annual changes were most pronounced in 2024 — Work In Process slipped 12.47% — and 2026, when it surged 62.86%.
- Alkermes' Work In Process stood at $76.2 million in 2022, then dropped by 9.69% to $68.8 million in 2023, then climbed by 16.02% to $79.9 million in 2024, then gained by 13.31% to $90.5 million in 2025, then climbed by 20.66% to $109.2 million in 2026.
- Business Quant data shows ALKS's Work In Process at $109.2 million in Q2 2026, $120.8 million in Q1 2026, and $90.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.50 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.20 Mn |
| Mar 31, 2026 | 120.84 Mn |
| Dec 31, 2025 | 90.50 Mn |
| Sep 30, 2025 | 89.41 Mn |
| Jun 30, 2025 | 81.39 Mn |
| Mar 31, 2025 | 74.20 Mn |
| Dec 31, 2024 | 79.87 Mn |
| Sep 30, 2024 | 77.01 Mn |
| Jun 30, 2024 | 69.09 Mn |
| Mar 31, 2024 | 72.52 Mn |
| Dec 31, 2023 | 68.84 Mn |
| Sep 30, 2023 | 73.46 Mn |
| Jun 30, 2023 | 78.93 Mn |
| Mar 31, 2023 | 74.66 Mn |
| Dec 31, 2022 | 76.23 Mn |
| Sep 30, 2022 | 79.82 Mn |
| Jun 30, 2022 | 70.44 Mn |
| Mar 31, 2022 | 64.39 Mn |
| Dec 31, 2021 | 59.11 Mn |
| Sep 30, 2021 | 50.89 Mn |